Novel signaling pathways regulated by the liver x receptor in age-related macular degeneration

NIH RePORTER · NIH · R01 · $485,214 · view on reporter.nih.gov ↗

Abstract

SUMMARY Age-related macular degeneration (AMD) is the leading cause of vision loss in the Western World. The fundamental abnormalities occurring in retinal pigment epithelial (RPE) cells leading to their progressive dysfunction and eventually atrophy in AMD are not known. Multiple epidemiological, biochemical, and histological studies highlight the role of altered cholesterol metabolism in the pathogenesis of AMD. The liver x receptor is an important regulator of reverse cholesterol transport. Beyond this established function it has also been shown to regulate inflammation, cell metabolism and apoptosis. We have recently found that aged LXR knockout mice develop cardinal features of dry AMD including accumulation of cholesterol and neutral lipids within Bruch's membrane and development of significant sub-RPE deposits. Herein we propose to investigate the role of two modulators of LXR in RPE biology and pathogenesis of AMD.

Key facts

NIH application ID
9881295
Project number
5R01EY027802-03
Recipient
DUKE UNIVERSITY
Principal Investigator
Goldis Malek
Activity code
R01
Funding institute
NIH
Fiscal year
2020
Award amount
$485,214
Award type
5
Project period
2018-03-01 → 2022-02-28